Article Sidebar
Published:
Jun 4, 2018Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Assessment of the knowledge, attitude and practice of pharmacovigilance by pharmacists in two states in southeastern Nigeria
Abstract
Purpose: To evaluate knowledge, attitude and practice (KAP) of pharmacovigilance (PV) and adverse drug reactions (ADRs) reporting among community and hospital pharmacists in Abia and Imo States of Nigeria.
Methods: A cross-sectional survey was done using a validated questionnaire distributed among hospital and community pharmacists in the two States.
Results: Out of the 227 copies of the questionnaire administered, 169 (74.4%) were usable. Only 22% of all the pharmacists had postgraduate qualification but 78.0% had more than five years postqualification experience. All respondents were aware of the concept of PV; 73.4% had seen a patient with ADR while 17.7% had not seen the ADR reporting form in use in Nigeria. Only 24.3% had officially reported an ADR. Factors that affected reporting were lack of incentive (52.1%), role conflict (69.2%), and role overload (72.8%). Mean score for KAP-related questions was higher among hospital pharmacists than their community counterparts.
Conclusion: The study has shown that while all pharmacists were aware of PV, the attitude and practice of many of them constituted a challenge and accounted for poor level of reporting.
Keywords: Adverse drug reactions, Community pharmacists, Hospital pharmacists, National Pharmacovigilance Centre
